Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

The 2026 Defence Investment Plan reveals that the Royal Air Force’s next revolution will not depend solely on new aircraft such as GCAP, but on a digital architecture capable of accelerating ...

For years, Mars has sat in an awkward middle ground, too geologically quiet to look like Earth. At the same time, it is too ...

Tesla and SpaceX remain extraordinary companies, but at current valuations, investors are being asked to pay today for ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

AI uses a modern Large Language Model (LLM), but it doesn't simply retrieve facts from a database. Instead, it navigates a ...

According to Partners Group’s Private Markets Chartbook Q2, AI demand is now accelerating faster than capacity.

Background Comparative evidence on the diagnostic yield of endobronchial ultrasound (EBUS)-guided sampling techniques for ...

This article outlines the 8 top GEO software platforms for 2026. It will concentrate on their capabilities in the technical ...

Audited Results for the Year Ended 28 February 2026 MANTENGU LIMITED (formerly Mantengu Mining Limited) Incorporated in the Republic of South Africa (Registration number: 1987/004821/06) Share code: ...

Bodog reports that prediction markets, especially on Kalshi, reflect public obsessions with events like elections and sports, ...

2. Comments on the draft Guidanceare invited from regulated entities, members of public and other stakeholders by July 24, 2026. The comments / feedback may be submitted through the link under the ...